Skip to main content
. Author manuscript; available in PMC: 2015 Mar 5.
Published in final edited form as: Urol Oncol. 2013 Aug 2;32(1):43.e23–43.e30. doi: 10.1016/j.urolonc.2013.05.008

Table 2.

Antibodies used in this study

Name Source Dilution
Anti-cytokeratin 7 (CK7) Dako Corp., Carpinteria, CA 1:200
Anti-CAIX Novus Biologicals, Littleton, CO 1:200
Anti-CD10 Leica, Newcastle, UK 1:100
Anti-CD117 Dako Corp., Carpinteria, CA 1:200
Anti-Ku70 Abcam, Cambridge, MA 1:200
Anti–human-specific CD31 Dako Corp., Carpinteria, CA 1:20
Universal biotinylated horse anti-mouse/rabbit IgG Vector Laboratories Inc., Burlingame, CA 1:1000